Esperion Therapeutics, Inc. financial data

Symbol
ESPR on Nasdaq
Industry
Pharmaceutical Preparations
Location
3891 Ranchero Drive, Suite 150, Ann Arbor, MI
State of incorporation
DE
Fiscal year end
December 31
Former names
HDL THERAPEUTICS INC (to 5/7/2008)
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 184 % -15.9%
Quick Ratio 45.8 % +15.5%
Debt-to-equity -185 % -11.1%
Return On Equity 23.7 % -59.2%
Return On Assets -27.9 % +68%
Operating Margin 5.57 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 197M shares +73.3%
Entity Public Float 143M USD -66.3%
Common Stock, Value, Issued 195K USD +74.1%
Weighted Average Number of Shares Outstanding, Basic 195M shares +74.2%
Weighted Average Number of Shares Outstanding, Diluted 195M shares +74.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 295M USD +187%
Operating Income (Loss) 16.5M USD +41.8%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -86.8M USD +58.4%
Earnings Per Share, Basic -0.53 USD/shares +77.4%
Earnings Per Share, Diluted -0.55 USD/shares +76.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 145M USD +26%
Accounts Receivable, after Allowance for Credit Loss, Current 67.8M USD +59.1%
Inventory, Net 80.1M USD +55.7%
Assets, Current 308M USD +40.9%
Property, Plant and Equipment, Net 281K USD +4583%
Operating Lease, Right-of-Use Asset 6.22M USD +106%
Intangible Assets, Net (Excluding Goodwill) 56K USD 0%
Assets 314M USD +41.9%
Accounts Payable, Current 34.9M USD +33%
Employee-related Liabilities, Current 11.1M USD +35.1%
Contract with Customer, Liability, Current 15.1M USD -23.6%
Liabilities, Current 166M USD +20.5%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 3.3M USD +61%
Liabilities 684M USD +8.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) -1.58B USD -5.81%
Stockholders' Equity Attributable to Parent -370M USD +9.71%
Liabilities and Equity 314M USD +41.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 53.8M USD
Net Cash Provided by (Used in) Financing Activities 90.6M USD +83.1%
Net Cash Provided by (Used in) Investing Activities -73K USD -100%
Common Stock, Shares Authorized 480M shares 0%
Common Stock, Shares, Issued 197M shares +73%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 144M USD +617%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 145M USD +26%
Deferred Tax Assets, Valuation Allowance 396M USD +12.3%
Deferred Tax Assets, Gross 397M USD +12.5%
Operating Lease, Liability 4.57M USD +336%
Depreciation 0 USD -100%
Payments to Acquire Property, Plant, and Equipment 73K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -86.8M USD +58.3%
Lessee, Operating Lease, Liability, to be Paid 5.1M USD +301%
Property, Plant and Equipment, Gross 2.01M USD -25.9%
Operating Lease, Liability, Current 2.74M USD +199%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.81M USD +935%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.84M USD +299%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 529K USD +137%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.14M USD +617%
Deferred Tax Assets, Operating Loss Carryforwards 259M USD +6.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 2.1M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 169K USD +3.05%
Additional Paid in Capital 1.26B USD +11.1%
Preferred Stock, Shares Outstanding 0 shares
Interest Expense 58.6M USD +2.59%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%